Centessa Pharmaceuticals (CNTA)
(Delayed Data from NSDQ)
$9.54 USD
-0.32 (-3.25%)
Updated Jul 15, 2024 04:00 PM ET
After-Market: $9.56 +0.02 (0.21%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.39 | 0.00% |
Earnings Summary
For their last quarter, Centessa Pharmaceuticals (CNTA) reported earnings of -$0.38 per share, beating the Zacks Consensus Estimate of $-0.41 per share. This reflects a positive earnings surprise of 7.32%. Look out for CNTA's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.39 per share, reflecting a year-over-year decrease of 50%.
Earnings History
Price & Consensus
Zacks News for CNTA
The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics
CNTA: What are Zacks experts saying now?
Zacks Private Portfolio Services